Skip to search formSkip to main contentSkip to account menu

Maprotiline

Known as: 9,10-Ethanoanthracene-9(10H)-propanamine, N-methyl-, Maprotylina, Dibencycladine 
A bridged-ring tetracyclic antidepressant that is both mechanistically and functionally similar to the tricyclic antidepressants, including side… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
In the choice of an antidepressant drug the clinician must often consider the presence of a cardiovascular comorbidity in… 
1983
1983
Maprotiline, amoxapine, and their metabolites were determined in plasma by three separate procedures, each of which involves a… 
1983
1983
In a double-blind study, 49 geriatric patients suffering from primary major depression were treated with maprotiline or doxepin… 
1983
1983
The simultaneous serum analysis of amoxapine (AMOX) and its major metabolite 8-hydroxyamoxapine (8-OH AMOX), and maprotiline (MAP… 
1982
1982
Present methodological problems in assessing the clinical efficacy of putative antidepressants require testing of various new… 
1982
1982
50 patients suffering from endogenous depression were admitted to a double-blind study comparing the efficacy of nomifensine and… 
1981
1981
: The antidepressant effect of maprotiline, a tetracyclic compound, was compared with that of imipramine in a four-week, double… 
1979
1979
A double-blind controlled, cross-over trial was carried out in 70 depressed patients to compare the effectiveness and… 
1977
1977
In a three-week study of 10,000 general practice patients with depressive illness, a single dose of maprotiline 75 mg at night… 
1974
1974
  • A. Levin
  • 1974
  • Corpus ID: 36184606
Patients suffering from depressive illness were admitted to a double-blind trial comparing the efficacy and tolerability of…